Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
NSPR

NSPR - InspireMD Inc Stock Price, Fair Value and News

$1.650.00 (0.00%)
Market Closed

42/100

NSPR

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

42/100

NSPR

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$1.45

Target 3M

$1.58

Target 6M

$1.53

NSPR Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NSPR Price Action

Last 7 days

1.9%

Last 30 days

-12.2%

Last 90 days

-24.7%

Trailing 12 Months

-32.1%

NSPR RSI Chart

NSPR Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NSPR Valuation

Market Cap

69.9M

Price/Earnings (Trailing)

-1.51

Price/Sales (Trailing)

8.99

EV/EBITDA

-0.19

Price/Free Cashflow

-2.05

NSPR Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$1.45

Target 3M

$1.58

Target 6M

$1.53

NSPR Fundamentals

NSPR Revenue

Revenue (TTM)

7.8M

Rev. Growth (Yr)

39.39%

Rev. Growth (Qtr)

41.9%

NSPR Earnings

Earnings (TTM)

-46.2M

Earnings Growth (Yr)

-61.06%

Earnings Growth (Qtr)

3.37%

NSPR Profitability

Operating Margin

68.76%

EBT Margin

-410.67%

Return on Equity

-72.06%

Return on Assets

-58.87%

Free Cashflow Yield

-48.75%

NSPR Investor Care

Shares Dilution (1Y)

62.44%

Diluted EPS (TTM)

-0.82

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20257.0M7.1M7.8M0
20246.5M6.6M6.8M7.0M
20235.2M5.3M5.5M6.2M
20224.7M5.2M5.5M5.2M
20212.5M3.2M3.3M4.5M
20204.3M3.3M3.3M2.5M
20193.0M3.4M3.5M3.7M
20183.2M3.6M3.6M3.6M
20171.9M2.0M2.2M2.8M
20162.4M2.3M2.1M1.9M
20151.8M2.3M2.7M2.3M
20146.1M4.8M3.5M2.8M
20134.3M4.9M5.9M6.1M
20125.5M5.3M3.9M3.9M
20114.5M4.7M5.4M6.0M
20100004.9M
Get all data in R, Python etc through our Historical Stock Data APIs

About InspireMD Inc

NSPR
InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Delivery System, a mesh-covered self-expanding carotid stent; SwitchGuard, a non-invasive transcarotid artery revascularization device; and NGuard EPS for treating acute stroke with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.
 CEO
 WEBSITEinspiremd.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES55

InspireMD Inc Frequently Asked Questions

NSPR is the stock ticker symbol of InspireMD Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of InspireMD Inc is 69.91 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check NSPR's fair value in chart for subscribers.

The fair value guage provides a quick view whether NSPR is over valued or under valued. Whether InspireMD Inc is cheap or expensive depends on the assumptions which impact InspireMD Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NSPR.

As of Wed Jan 28 2026, NSPR's PE ratio (Price to Earnings) is -1.51 and Price to Sales (PS) ratio is 8.99. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NSPR PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, InspireMD Inc has provided -0.584 (multiply by 100 for percentage) rate of return.